# Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions

> **NCT04918615** · NA · UNKNOWN · sponsor: **Shanghai MicroPort Medical (Group) Co., Ltd.** · enrollment: 236 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **PROCEDURE:** PCI

## Key facts

- **NCT ID:** NCT04918615
- **Lead sponsor:** Shanghai MicroPort Medical (Group) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-28
- **Primary completion:** 2023-10-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2023-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04918615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04918615, "Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04918615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*